Mild depressive symptoms are associated with elevated C-reactive protein and proinflammatory cytokine levels during early to midgestation: A prospective pilot study

Journal of Women's Health

Volumn 22, Issue 4, 2013, Pages 385-389

  Azar, Rima ^a   Mercer, Darren ^b  

^a MOUNT ALLISON UNIVERSITY   (Canada)

^b Hôpital du Sacré Coeur de Montréal   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; DEPRESSION; FEMALE; GESTATION PERIOD; HUMAN; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT HEALTH QUESTIONNAIRE 9; PILOT STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-6; PILOT PROJECTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANT WOMEN; PROSPECTIVE STUDIES; QUESTIONNAIRES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84876237413     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3785     Document Type: Article

References (14)

1. Canals J, Esparo G, Fernadez-Baillard JD. How anxiety lev-els during pregnancy are linked to personality dimensions and sociodemographic factors. Person. Individ Diff 2002;33: 253-259.
2. O'Brien L, Laporte A, Koren G. Estimating the economic costs of antidepressant discontinuation during pregnancy. Can J Psychiatry 2009;54:399-407.
3. Ross LE, McLean LM. Anxiety disorders during pregnancy and the postpartum period: A systematic review. J Clin Psychiatry 2006;67:1285-1298.
4. Teixeira C, Figeiredo B, Conde A, Pacheco A, Costa R. An-xiety and depression during pregnancy in women and men. J Affect Disord 2009;119:142-148.
5. Coussons-Read ME, Okun ML, Nettles CD. Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain Behav Immun 2007;21: 343-50.
6. Christian LM, Franco A, Glaser R, Iams JD, Sherisan J. De-pressive symptoms predict exaggerated inflammatory re-sponses to an in vivo immune challenge among pregnant women. Short communication. Brain Behav Imm 2010;24: 49-53.
7. Kendall-Tackett K. Review: A new paradigm for depression in new mothers: The central role of inflammation and how breastfeeding and anti-inflammatory treatments protect maternal mental health. Int Breastfeed J 2007;2:1-14.
8. Blackmore ER, Moynihan JA, Rubinow DR, Pressman EK, Gilchrist M, O'Connor TG. Psychiatric symptoms and proinflammatory cytokines in pregnancy. Psychosom Med 2001;73:656-663.
9. Meier-Ewert HK, Ridker PM, Rifai N, et al. Absence of di-urnal variation of C-reactive protein concentrations in heal-thy human subjects. Clin Chem 2001;47:426-430.
10. Kroenke, KM, Spitzer RLM, Williams JBD. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613.
11. Azar R, Nolan R, Stewart DE. Listening to the heart-brain talk: Persistent depressive symptoms are associated with hsCRP in apparently healthy individuals at high risk for coronary artery disease. Eur J Prev Cardiol 2012;19:857-863.
12. Miller GE, Stetler, CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279-1283.
13. Maes M, Ombelet W, De Jongh R, Kennis G, Bosman E. The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sen-sitization of the inflammatory response system. J Affect Disord 2001;63:85-92.
14. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom Med 2012;71:171-186.